Colgate-Palmolive Company $CL Shares Sold by Brown Advisory Inc.

Brown Advisory Inc. cut its holdings in Colgate-Palmolive Company (NYSE:CL) by 2.3% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 491,496 shares of the company’s stock after selling 11,485 shares during the period. Brown Advisory Inc. owned about 0.06% of Colgate-Palmolive worth $44,677,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Westside Investment Management Inc. raised its position in shares of Colgate-Palmolive by 85.5% during the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after purchasing an additional 130 shares during the last quarter. Saudi Central Bank purchased a new position in Colgate-Palmolive in the 1st quarter valued at about $29,000. Vermillion & White Wealth Management Group LLC grew its holdings in shares of Colgate-Palmolive by 86.1% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after buying an additional 155 shares in the last quarter. Ransom Advisory Ltd purchased a new position in shares of Colgate-Palmolive during the first quarter valued at approximately $33,000. Finally, Y.D. More Investments Ltd purchased a new stake in Colgate-Palmolive in the 1st quarter worth approximately $37,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.6%

Shares of NYSE CL opened at $78.04 on Friday. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.60 and a current ratio of 0.93. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $100.18. The stock’s 50-day simple moving average is $78.42 and its 200-day simple moving average is $84.10. The firm has a market cap of $62.91 billion, a price-to-earnings ratio of 21.86, a PEG ratio of 5.53 and a beta of 0.30.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, October 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. During the same quarter in the prior year, the business posted $0.91 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 1.9% on a year-over-year basis. As a group, equities analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 14th. Investors of record on Friday, October 17th were paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date was Friday, October 17th. Colgate-Palmolive’s payout ratio is 58.26%.

Analyst Upgrades and Downgrades

CL has been the subject of several analyst reports. Raymond James Financial cut their price target on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a report on Monday, October 20th. JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $88.00 to $87.00 and set an “overweight” rating on the stock in a research report on Monday, November 3rd. The Goldman Sachs Group decreased their price target on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a research note on Thursday, October 2nd. UBS Group dropped their price objective on shares of Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating for the company in a research note on Monday, November 3rd. Finally, Barclays decreased their target price on shares of Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 4th. Nine research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $89.87.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.